Fig. 6From: A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinomaClinical application of the 5-NKRLSig model in HCC. The difference in risk score by Female A-B, Male C-D, Age < 65 E–F, Age ≥ 65 G-H, Stage I/II I-J, Stage III/IV K-L, Grade I/II M–N, Grade III/IV O-P of HCCBack to article page